Lucite tombstone celebrating Series A funding for Trailhead Biosystems. The Cleveland-based biotechnology company is focused on the application of machine-enabled technology. (21ADH001)

Lucite deal toy celebrating a public offering of American Depositary Shares, and concurrent private placement, by Calliditas Therapeutics. The pharmaceutical firm is based in Stockholm, Sweden. (20ALJ348)

Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel. (20ALJ348)

Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel. (9ALJ621)

Crystal deal toy, incorporating an interior, 3-D etching of Thor's hammer, commemorating a private placement by pharmaceutical company Photocure ASA. Based in Oslo, Norway, Photocure specializes in photodynamic therapies that make use of light-activated drugs. (20LJW163)

Custom financial tombstone commemorating the ipo of New Zealand-based medicinal cannabis firm Rua Bioscience. (20ALJ334)

Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines. (20ALJ334)

Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches. (20ALJ356)

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma's migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial. (20ALJ356)

Crystal deal toy commemorating a loan facility provided for Biohaven Pharmaceuticals, based in New Haven, Connecticut. (20ALJ278)

Custom crystal deal toy commemorating a follow-on offering by Windtree Therapeutics. The Pennsylvania-based firm is focused on medical devices and drug therapies for the treatment of pulmonary and cardiovascular diseases. (20AJH070)

Deal tombstone recognizing a follow-on offering by Pennsylvania-based biotech firm Windtree Therapeutics. (20AH070)

Custom deal toy celebrating the initial public offering by South Korean firm SK Biopharmaceuticals. The listing on Seoul's main stock exchange was the largest in South Korea since 2017. (20ALJ243).

Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors. (9AKL619)

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau. (20ALJ071)

Custom deal tombstone commemorating the acquisition of Van London, a Texas-based designer and manufacturer of high-quality sensors for the industrial, lab, and biotech markets. (9AKL686)

Custom Lucite tombstone recognizing a follow-on offering by Translate Bio. The Boston-area therapeutics firm focuses on diseases caused by protein or gene dysfunction. (9ALJ491)

Custom deal toy marking a follow-on stock offering by Translate Bio. The biotech firm specializes in the treatment of diseases caused by protein or gene dysfunction. (9ALJ491)

Custom financial tombstone marking a private placement and direct offering by Yield10 Bioscience. The Woburn, Massachusetts-based company develops seed technology to increase crop yield. (9AMF367)

Crystal deal toy marking two offerings by Yield10 Bioscience, which specializes in the development of high-yield seeds for the agricultural and food industries. (9AMF367)

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases. (20ALJ110)

Lucite tombstone marking the acquisition of Catalyst Regulatory Services, which provides regulatory support for biopharmaceutical firms. (20AMF027)

Lucite financial tombstone marking a follow-on offering by Englewood, Colorado-based Viveve Medical. (20AMF021)

Lucite tombstone commemorating a follow-on offering by medTech firm Viveve Medical, which specializes in women's health. (20AMF021)

Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies. (9ALJ524)

Lucite tombstone commemorating a public offering of stock by Achieve Life Sciences. Achieve is engaged in the development and cytisinicline, a plant-based alkaloid used for smoking cessation and nicotine addiction. (20AMF022)

(20AKL59)

(20AKL59)

Financial tombstone marking the acquisition of Quadrant Scientific. The firm specializes in chemical and microbiological testing and environmental monitoring services for the pharmaceutical, biotechnology, and medical device sectors. (20ALJ029)

Custom Lucite tombstone commemorating the acquisition of Quadrants Scientific, a San Diego-based chemical and microbiological testing laboratory. (20ALJ029)